» Articles » PMID: 36339598

Extracts Induce Apoptosis and Inhibit Tumor Invasion Blockage of the PI3K/AKT Signaling in Melanoma Cells

Overview
Journal Front Pharmacol
Date 2022 Nov 7
PMID 36339598
Authors
Affiliations
Soon will be listed here.
Abstract

Melanoma, the most aggressive and deadliest form of skin cancer, has attracted increased attention due to its increasing incidence worldwide. The (CM) has long been used as a classical traditional Chinese medicine (TCM) to treat various diseases, including cancer. The bioactive components and underlying mechanisms, however, remain largely unknown. The current study aims to investigate the anti-melanoma effects of CM and potential mechanisms through combined network pharmacology and bioinformatic analyses, and validated by and experiments. We report here that CM has anti-melanoma activity both and . Furthermore, 25 bioactive compounds in CM were found to share 142 melanoma targets, and network pharmacology and enrichment analyses suggested that CM inhibits melanoma through multiple biological processes and signaling pathways, particularly the PI3K-AKT signaling inhibition and activation of apoptotic pathways, which were further confirmed by biochemical and histological examinations. Finally, partial CM-derived bioactive compounds were found to show anti-melanoma effects, validating the anti-melanoma potential of bioactive ingredients of CM. Taken together, these results reveal bioactive components and mechanisms of CM in inhibiting melanoma, providing them as potential anti-cancer natural products for the treatment of melanoma.

Citing Articles

Enterobactin inhibits microbiota-dependent activation of AhR to promote bacterial sepsis in mice.

Keskey R, Xiao J, Hyoju S, Lam A, Kim D, Sidebottom A Nat Microbiol. 2025; 10(2):388-404.

PMID: 39779878 PMC: 11905502. DOI: 10.1038/s41564-024-01882-9.


Treatment of chronic obstructive pulmonary disease by traditional Chinese medicine Morin monomer regulated by autophagy.

Liu Z, Zeng Y, Li R, Yan Y, Yi S, Zhang K J Thorac Dis. 2024; 16(9):6052-6063.

PMID: 39444855 PMC: 11494543. DOI: 10.21037/jtd-23-1836.


Widely Targeted Metabolomics Analysis to Reveal Metabolite of L. in Different Medicinal Parts.

Wang X, Qian Y, Wei M Molecules. 2024; 29(17).

PMID: 39274829 PMC: 11395776. DOI: 10.3390/molecules29173981.


Mulberroside A mitigates intervertebral disc degeneration by inhibiting MAPK and modulating Ppar-γ/NF-κB pathways.

Xu T, Zhao H, Fang X, Wang S, Li J, Wu H J Inflamm (Lond). 2024; 21(1):32.

PMID: 39198816 PMC: 11360712. DOI: 10.1186/s12950-024-00398-7.


Predictive value of CCL2 in the prognosis and immunotherapy response of glioblastoma multiforme.

Deng L, Ren J, Li B, Wang Y, Jiang N, Wang Y BMC Genomics. 2023; 24(1):746.

PMID: 38057698 PMC: 10698956. DOI: 10.1186/s12864-023-09674-x.


References
1.
Sykes E, Mactier S, Christopherson R . Melanoma and the Unfolded Protein Response. Cancers (Basel). 2016; 8(3). PMC: 4810114. DOI: 10.3390/cancers8030030. View

2.
Du J, Dong Z, Tan L, Tan M, Zhang F, Zhang K . Tubeimoside I Inhibits Cell Proliferation and Induces a Partly Disrupted and Cytoprotective Autophagy Through Rapidly Hyperactivation of MEK1/2-ERK1/2 Cascade via Promoting PTP1B in Melanoma. Front Cell Dev Biol. 2021; 8:607757. PMC: 7773826. DOI: 10.3389/fcell.2020.607757. View

3.
Carr S, Smith C, Wernberg J . Epidemiology and Risk Factors of Melanoma. Surg Clin North Am. 2019; 100(1):1-12. DOI: 10.1016/j.suc.2019.09.005. View

4.
Ji H, Zhang K, Pan G, Li C, Li C, Hu X . Deoxyelephantopin Induces Apoptosis and Enhances Chemosensitivity of Colon Cancer via miR-205/Bcl2 Axis. Int J Mol Sci. 2022; 23(9). PMC: 9099879. DOI: 10.3390/ijms23095051. View

5.
Zuo J, Wang X, Liu Y, Ye J, Liu Q, Li Y . Integrating Network Pharmacology and Metabolomics Study on Anti-rheumatic Mechanisms and Antagonistic Effects Against Methotrexate-Induced Toxicity of Qing-Luo-Yin. Front Pharmacol. 2019; 9:1472. PMC: 6305420. DOI: 10.3389/fphar.2018.01472. View